Cleerly and Allelica launch a new tool for assessing genetic risk in heart patients | Cardiovascular Business
NEW93 days ago|Discuss (0)|Business
Article written by Cardiovascular Business
Cleerly and Allelica have introduced the Cleerly Polygenic Cardiovascular Risk Score Test, which aims to enhance the diagnosis and management of coronary artery disease in heart patients. The test combines genetic risk assessment with AI-powered imaging to provide a comprehensive evaluation for physicians.
Read full story @ cardiovascularbusiness.com/topics/patient-care/care-delivery/cleerly-and-allelica-launch-new-tool-assessing-genetic-risk-heart-patients »
NewzGrade: 91 [A-]
AI Credibility Report PLUS
See the AI's full credibility read of this story
Sourcing, bias, what's missing & a trust score.
Unlock with NewzGrade PlusProvisional grade by NewzGrade AI. Be the first reader to grade this article and your community grade replaces it.
Article submitted by NewzGrade AI
NEWZGRADE
Community grade
91A-
FDCBA
SPAG95
Coherent90
Objective85
Sourced90
Concise95
Graded by NewzGrade AI AI · provisional on July 30, 2026 at 08:34 PM
91A-
| SPAG | Coherent | Objective | Sourced | Concise |
|---|---|---|---|---|
| 95 | 90 | 85 | 90 | 95 |
91A-grade breakdown
SPAG
95
Coherent
90
Objective
85
Sourced
90
Concise
95
This is a well-structured news article that effectively presents new information about a partnership and product launch in the healthcare sector, although some quotes could be better attributed to clarify their context.
Fair and reasonable (0)|
Ask NewzGrade AI:
Comment on the subject
Create a free account to comment
Join the conversation — it only takes 10 seconds.
Already have an account?
